Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 6/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
| ▸ | FPR1 | P21462 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21735754 | 0.94 | S1PR1 (0.38) | S1PR1PTPN1S1PR3ALOX5PPARG | |
| SCHEMBL22625050 | 0.91 | NPC1 (0.39) | S1PR1MAOAMAOBNPC1RAB9A | |
| SCHEMBL21735752 | 0.91 | S1PR1 (0.39) | S1PR1S1PR3ALOX5PTGESMAOA | |
| SCHEMBL21735731 | 0.91 | S1PR1 (0.38) | S1PR1S1PR3ALOX5PPARAPTGES | |
| SCHEMBL21735049 | 0.90 | S1PR1 (0.43) | S1PR1PTPN1S1PR3ALOX5PPARG | |
| SCHEMBL21735284 | 0.90 | S1PR1 (0.43) | S1PR1PTPN1S1PR3ALOX5PPARG | |
| SCHEMBL21735285 | 0.87 | ALOX5 (0.36) | S1PR1PTPN1ALOX5PPARGPPARA | |
| SCHEMBL26291483 | 0.86 | S1PR1 (0.48) | S1PR1PTPN1S1PR3ALOX5PPARG | |
| SCHEMBL21735358 | 0.85 | S1PR1 (0.42) | S1PR1PTPN1S1PR3ALOX5PPARG | |
| SCHEMBL22624954 | 0.85 | MAOB (0.35) | S1PR1S1PR3MAOAMAOBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11014901-B2 | Hydrophobic compounds for optically active devices | MERCK PATENT GMBH (DE) | 2021-05-25 | — | — | US | disclosed |
| EP-3583091-B1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-11-04 | — | — | EP | disclosed |
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | UACA, CRYZ, TRPA1 | S1PR1 3951/4885PTPN1 4838/4885S1PR3 2314/4885 |
| US-11014901-B2 | Hydrophobic compounds for optically active devices | UACA, CRYZ, TRPA1 | S1PR1 3951/4885PTPN1 4838/4885S1PR3 2314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.